LIVING WITH RARITY: THE RESILIENT JOURNEY OF FIDE MIRÓN

Born in Spain in 1974, Fide Mirón Torrente appeared healthy until six months old, when severe skin blistering and dark urine led to a diagnosis of congenital erythropoietic porphyria (CEP), or Günther disease. This exceptionally rare genetic disorder impairs heme production, causing toxic porphyrins to accumulate. Light exposure triggers severe blistering, permanent tissue damage, and facial and limb loss, alongside severe anemia.

Throughout early childhood, Fide survived on biweekly blood transfusions donated primarily by her father. Tragedic loss struck at age nine when her father died in an accident, leaving her dependent on public blood banks until her condition unexpectedly stabilized around age 14. Despite enduring social isolation and profound physical changes, she pursued higher education, earning a degree in social work.

Fide transformed her lived experience into powerful advocacy. She became the president of the Spanish Porphyria Association and a key leader in the Spanish Federation of Rare Diseases (FEDER). Bridging the gap between patients and medical science, she collaborated with researchers at CIC bioGUNE, providing vital human perspective to molecular research on CEP.

Today, Fide stands as a prominent international voice for rare diseases, turning decades of physical hardship into a mission to ensure no patient faces medical rarity alone.